209 related articles for article (PubMed ID: 28745916)
1. Experiences and Perceived Social Support among Iranian Men on Methadone Maintenance Therapy: A Qualitative Study.
Aghakhani N; Lopez V; Cleary M
Issues Ment Health Nurs; 2017 Sep; 38(9):692-697. PubMed ID: 28745916
[TBL] [Abstract][Full Text] [Related]
2. Social Support Among Women Undergoing Methadone Maintenance Treatment in Iran.
Rahimi S; Raheimi S; Jalali A; Jalali R
J Addict Nurs; 2018; 29(3):179-187. PubMed ID: 30180004
[TBL] [Abstract][Full Text] [Related]
3. Outcome evaluation of the opioid agonist maintenance treatment in Iran.
Esmaeili HR; Ziaddinni H; Nikravesh MR; Baneshi MR; Nakhaee N
Drug Alcohol Rev; 2014 Mar; 33(2):186-93. PubMed ID: 24428135
[TBL] [Abstract][Full Text] [Related]
4. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
Farnia M; Ebrahimi B; Shams A; Zamani S
Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".
Salsitz E; Wiegand T
J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Social Support and Attachment Style on Quality of Life and Readiness to Change in a Sample of Individuals Receiving Medication-Assisted Treatment for Opioid Dependence.
Cavaiola AA; Fulmer BA; Stout D
Subst Abus; 2015; 36(2):183-91. PubMed ID: 25839214
[TBL] [Abstract][Full Text] [Related]
7. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
[TBL] [Abstract][Full Text] [Related]
8. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
Winstock AR; Lintzeris N; Lea T
Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
[TBL] [Abstract][Full Text] [Related]
9. Stigma and its determinants among male drug dependents receiving methadone maintenance treatment.
Etesam F; Assarian F; Hosseini H; Ghoreishi FS
Arch Iran Med; 2014 Feb; 17(2):108-14. PubMed ID: 24527971
[TBL] [Abstract][Full Text] [Related]
10. Perceived barriers to methadone maintenance treatment among Iranian opioid users.
Khazaee-Pool M; Moeeni M; Ponnet K; Fallahi A; Jahangiri L; Pashaei T
Int J Equity Health; 2018 Jun; 17(1):75. PubMed ID: 29890990
[TBL] [Abstract][Full Text] [Related]
11. Using the PRECEDE model in understanding determinants of quality of life among Iranian male addicts.
Matin BK; Jalilian F; Alavije MM; Ashtarian H; Mahboubi M; Afsar A
Glob J Health Sci; 2014 Jun; 6(6):19-27. PubMed ID: 25363110
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
Notley C; Blyth A; Maskrey V; Pinto H; Holland R
Subst Abus; 2015; 36(2):232-9. PubMed ID: 25127184
[TBL] [Abstract][Full Text] [Related]
13. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
[TBL] [Abstract][Full Text] [Related]
14. Multi-Family Therapy with a Reflecting Team: A Preliminary Study on Efficacy among Opiate Addicts in Methadone Maintenance Treatment.
Garrido-Fernández M; Marcos-Sierra JA; López-Jiménez A; Ochoa de Alda I
J Marital Fam Ther; 2017 Apr; 43(2):338-351. PubMed ID: 27747887
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Group Motivational Interviewing in the Degree of Drug Craving in the Addicts Under the Methadone Maintenance Treatment (MMT) in South East of Iran.
Navidian A; Kermansaravi F; Tabas EE; Saeedinezhad F
Arch Psychiatr Nurs; 2016 Apr; 30(2):144-9. PubMed ID: 26992862
[TBL] [Abstract][Full Text] [Related]
16. Methadone maintenance patients show a selective deficit to reverse positive outcomes in drug-related conditions compared to medication free prolonged opiate abstinence.
Levy-Gigi E; Kéri S; Shapiro AR; Sason A; Adelson M; Peles E
Drug Alcohol Depend; 2014 Nov; 144():111-8. PubMed ID: 25220895
[TBL] [Abstract][Full Text] [Related]
17. Opioid dependence - management in general practice.
Frei M
Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
[TBL] [Abstract][Full Text] [Related]
18. A good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals.
De Maeyer J; Vanderplasschen W; Camfield L; Vanheule S; Sabbe B; Broekaert E
Int J Nurs Stud; 2011 Oct; 48(10):1244-57. PubMed ID: 21481390
[TBL] [Abstract][Full Text] [Related]
19. Predictors of treatment retention in a major methadone maintenance treatment program in iran: a survival analysis.
Pashaei T; Moeeni M; Roshanaei Moghdam B; Heydari H; Turner NE; Razaghi EM
J Res Health Sci; 2014; 14(4):291-5. PubMed ID: 25503286
[TBL] [Abstract][Full Text] [Related]
20. Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients.
Sankey C; Setnik B; Harsanyi Z; Michalko K; Yang Z; Geoffroy P
J Opioid Manag; 2016; 12(2):149-59. PubMed ID: 27194200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
